ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500660 announcements Glaxosmith announcements and dividends declared BSE

Glaxosmith Complete list of announcements declared & dividend announcements by Glaxosmith 500660

Glaxosmith 500660 listed on BSE and deals in

Announcements and dividends declared by Glaxosmith 500660

GlaxoSmithKline PLC (GSK) Ex-Dividend Date Scheduled for August 19, 2021
GlaxoSmithKline PLC (GSK) will begin trading ex-dividend on August 19, 2021. A cash dividend payment of [CO].523 per share is scheduled to be paid on October 07, 2021. Shareholders who purchased GSK prior to the ex-dividend date are eligible for the cash di
Announcement as on 18 August 2021

GlaxoSmithKline Pharma Q1 results: Net profit up 9% at Rs 121 crore
Consolidated revenue from operations of the company stood at Rs 789.99 crore for the quarter under consideration. It was Rs 648.59 crore for the same period a year ago, it added.
Announcement as on 27 July 2021

GlaxoSmithKline Pharma Q1 net profit up 9% at Rs 121 crore
Drug firm GlaxoSmithKline Pharmaceuticals on Monday reported a 9.24 per cent rise in consolidated net profit to Rs 121.08 crore for the quarter ended June 30, 2021.
Announcement as on 26 July 2021

Sanofi and GlaxoSmithKline begin Phase 3 study of COVID-19 vaccine candidate
French pharmaceutical group Sanofi [s:fr: san] and U.K. drug company GlaxoSmithKline said they have begun global Phase 3 efficacy studies of their jointly produced COVID-19 candidate. The randomized, double-blind placebo controlled study will involve more
Announcement as on 27 May 2021

GlaxoSmithKline and Vir win FDA emergency authorization for COVID antibody treatment in adults and children
GlaxoSmithKline plc and Vir Biotechnology Inc. said the U.S. Food and Drug Administration has granted emergency use authorization to its single-dose monoclonal antibody treatment sotrovimab in mild-to-moderate COVID-19 in adults and pediatric patients w
Announcement as on 27 May 2021

Announcements by Glaxosmith first page | Next page | Prev page |

500660 Glaxosmith current price & indicator signals

Moving Averages for Glaxosmith

  • 5Day Average: 2351.26
  • 12Day Average: 2405.7
  • 20Day Average: 2402.07
  • 50Day Average: 2397.46
  • 100Day Average: 2436.45
  • 150Day Average: 2487.03
  • 200Day Average: 2561.43

500660 Indicators & signals

Indicator MACD (12,26,9)

2379.41, 2396.82, -4.56
Indicator MACD is in negative zone

Indicator ADX (14)

17.47, 15.47, 22.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500660 Glaxosmith are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Fri May 2026 2309.80 2295.00 to 2344.00 -0.47% 0.61 times
21 Thu May 2026 2320.75 2312.40 to 2377.00 -1.14% 0.54 times
20 Wed May 2026 2347.60 2343.60 to 2395.80 -1.73% 0.5 times
19 Tue May 2026 2388.90 2381.00 to 2421.90 -0.01% 0.26 times
18 Mon May 2026 2389.25 2372.10 to 2435.05 -2.07% 0.51 times
15 Fri May 2026 2439.75 2406.05 to 2458.60 0.91% 0.23 times
14 Thu May 2026 2417.75 2404.60 to 2460.65 0.45% 0.26 times
13 Wed May 2026 2406.85 2386.35 to 2493.00 -1.68% 1.16 times
12 Tue May 2026 2448.10 2412.00 to 2491.00 0.5% 0.73 times
11 Mon May 2026 2435.95 2428.95 to 2484.35 -1.96% 0.46 times
08 Fri May 2026 2484.70 2440.00 to 2505.00 0.23% 5.36 times
07 Thu May 2026 2478.95 2432.30 to 2488.40 2.25% 1.82 times

Videos related to: 500660 announcements Glaxosmith announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500660 announcements Glaxosmith announcements and dividends declared BSE

 

Back to top